We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
Cap. Flow
+$8.92M
Cap. Flow %
0.03%
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$92.9M
2
AMZN icon
Amazon
AMZN
+$62.6M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$46.3M
4
VMEO
Vimeo
VMEO
+$33.1M
5
UNH icon
UnitedHealth
UNH
+$28M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$49.9M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$43.5M
3
HUM icon
Humana
HUM
+$36.6M
4
VIPS icon
Vipshop
VIPS
+$35.6M
5
BN icon
Brookfield
BN
+$24M

Sector Composition

Rank Sector Weight
1 Financials 41.6%
2 Technology 16.13%
3 Healthcare 10.46%
4 Consumer Discretionary 9.11%
5 Communication Services 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBS icon
1676
UBS Group
UBS
$170B
-111
Closed -$1K
UHS icon
1677
Universal Health Services
UHS
$9.43B
-29
Closed -$4K
USPH icon
1678
US Physical Therapy
USPH
$1.14B
-335
Closed -$38K
VAC icon
1679
Marriott Vacations Worldwide
VAC
$3.24B
-4
Closed
VAL.WS icon
1680
Valaris Ltd Warrants
VAL.WS
$724M
$0 ﹤0.01%
10
VALE icon
1681
Vale
VALE
$63B
-103
Closed -$2K
WELL icon
1682
Welltower
WELL
$178B
-53
Closed -$4K
WEN icon
1683
Wendy's
WEN
$1.33B
$0 ﹤0.01%
29
WST icon
1684
West Pharmaceutical
WST
$23.1B
-17
Closed -$6K
X
1685
DELISTED
US Steel
X
$0 ﹤0.01%
+1
New +$25
QTTB icon
1686
Q32 Bio
QTTB
$450M
$0 ﹤0.01%
3
GRDX
1687
GridAI Technologies Corp
GRDX
$21.7M
0
AMBR
1688
Amber International Holding Ltd
AMBR
$136M
-50
Closed -$5K
ARTY
1689
iShares Future AI & Tech ETF
ARTY
$3.49B
-4,400
Closed -$197K
VIVS
1690
VivoSim Labs
VIVS
$1.44M
$0 ﹤0.01%
2
SWN
1691
DELISTED
Southwestern Energy Company
SWN
$0 ﹤0.01%
39
CHS
1692
DELISTED
Chicos FAS, Inc.
CHS
$0 ﹤0.01%
115
FRTX
1693
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
0
EQRXW
1694
DELISTED
EQRx, Inc. Warrant
EQRXW
$0 ﹤0.01%
+100
New +$217
RAD
1695
DELISTED
Rite Aid Corporation
RAD
$0 ﹤0.01%
37
HARP
1696
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$0 ﹤0.01%
7
CPUH.WS
1697
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$0 ﹤0.01%
110
ACOR
1698
DELISTED
Acorda Therapeutics
ACOR
$0 ﹤0.01%
3
AUD
1699
DELISTED
Audacy, Inc.
AUD
$0 ﹤0.01%
232
CYRN
1700
DELISTED
CYREN Ltd.
CYRN
$0 ﹤0.01%
5

Similar funds

First Manhattan's Q3 2021 Portfolio in Review

As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.

By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.

  • First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
  • First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
  • First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
  • First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
  • First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
  • First Manhattan opened 132 new positions and closed 93 in Q3 2021.
  • First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.

Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.